Correction: Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.

MLA

Robert A Harrison, et al. “Correction: Preclinical Antivenom-Efficacy Testing Reveals Potentially Disturbing Deficiencies of Snakebite Treatment Capability in East Africa.” PLoS Neglected Tropical Diseases, vol. 14, no. 8, Aug. 2020, p. e0008698. EBSCOhost, https://doi.org/10.1371/journal.pntd.0008698.

APA

Robert A Harrison, George O Oluoch, Stuart Ainsworth, Jaffer Alsolaiss, Fiona Bolton, Ana-Silvia Arias, José-María Gutiérrez, Paul Rowley, Stephen Kalya, Hastings Ozwara, & Nicholas R Casewell. (2020). Correction: Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa. PLoS Neglected Tropical Diseases, 14(8), e0008698. https://doi.org/10.1371/journal.pntd.0008698

Chicago

Robert A Harrison, George O Oluoch, Stuart Ainsworth, Jaffer Alsolaiss, Fiona Bolton, Ana-Silvia Arias, José-María Gutiérrez, et al. 2020. “Correction: Preclinical Antivenom-Efficacy Testing Reveals Potentially Disturbing Deficiencies of Snakebite Treatment Capability in East Africa.” PLoS Neglected Tropical Diseases 14 (8): e0008698. doi:10.1371/journal.pntd.0008698.